modelVoriconazole_Wang2024_reference

Extends from Pharmacolibrary.Pharmacokinetic.Models.PK_1C.

Information

name:voriconazole
ATC code:J02AC03
model:one compartment, IV dosing (PK_1C)
source:Wang J et al. 2024
population:elderly Chinese patients with invasive aspergillosis
measured compound:voriconazole
review:curated candidate
record page:pharmacolibrary-docs

Parameters as reported in the paper

parametervalueunitmeaning
typical clearance rate of voriconazole3.22L/hCL
typical volume of distribution194LV

About voriconazole

Voriconazole is an antifungal medicine used to treat serious fungal infections such as aspergillosis, candidiasis, and other systemic mycoses. It is authorised in the European Union and is included on the WHO list of essential medicines, so it is widely used for systemic fungal infections.

Summary written by glm-5.3-flash from Wikidata Q412236 and the WHO ATC classification and the EMA medicines list; not checked by a person.

Identity, molar mass and metabolites: Voriconazole.

References

  1. Wang J et al. (2024). Population Pharmacokinetics of Voriconazole and Dose Optimization in Elderly Chinese Patients. Journal of clinical pharmacology 64(2):253–263. DOI:10.1002/jcph.2357 PUBMED:37766506

Parameters

TypeNameDefaultDescription
RealCl_ref8.944444444444445e-07Cl [m3/s]
RealVd_ref0.194Vd [m3]
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.0009Volume of distribution per kg (default 0.9 L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)1bioavailability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)2.7777777777777776e-7clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1e-4administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Info › Therapeutic range (metadata, not used in equations)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008maximal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Info › Substance metadata
Modelica.Units.SI.MolarMassMM (from PK_1C)0molar mass [kg/mol]; 0 = not supplied (molar concentrations are then 0)
Info › Substance metadata (not used in equations)
Pharmacolibrary.Types.DoseLD50 (from PK_1C)0median lethal dose [mg/kg]; 0 = unknown

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)central-compartment elimination half-life = ln(2)*Vd/Cl (1-compartment approximation; NOT the terminal half-life of 2-/3-compartment models)

Revisions

  • 11/2026 generated by pharmacolibrary-dev export.pharmacolibrary_models from Wang_2024: parameters extracted from the paper by the pharmacolibrary-dev pipeline, model built by its engineer, reviewed: curated candidate